Shanghai Serum Bio Technology Co (SHSE:688163) Total Liabilities : ¥35.7 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Shanghai Serum Bio Technology Co Total Liabilities?

Shanghai Serum Bio Technology Co's Total Liabilities for the quarter that ended in Mar. 2024 was ¥35.7 Mil.

Shanghai Serum Bio Technology Co's quarterly Total Liabilities increased from Sep. 2023 (¥37.88 Mil) to Dec. 2023 (¥42.63 Mil) but then declined from Dec. 2023 (¥42.63 Mil) to Mar. 2024 (¥35.65 Mil).

Shanghai Serum Bio Technology Co's annual Total Liabilities increased from Dec. 2021 (¥33.26 Mil) to Dec. 2022 (¥44.86 Mil) but then declined from Dec. 2022 (¥44.86 Mil) to Dec. 2023 (¥42.63 Mil).

Shanghai Serum Bio Technology Co Total Liabilities Historical Data

The historical data trend for Shanghai Serum Bio Technology Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Serum Bio Technology Co Total Liabilities Chart

Shanghai Serum Bio Technology Co Annual Data

Trend

Dec13

Dec14

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

28.17

33.15

33.26

44.86

42.63

Shanghai Serum Bio Technology Co Quarterly Data
	Dec16	Dec17	Dec18	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															31.72	39.10	37.88	42.63	35.65

Shanghai Serum Bio Technology Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Shanghai Serum Bio Technology Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	24.986	+	(12.2	+	5.446
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	42.6

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	1128.473	-	1085.841
	=	42.6

Shanghai Serum Bio Technology Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	17.848	+	(12.356	+	5.446
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	35.7

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	1122.966	-	1087.315
	=	35.7

Shanghai Serum Bio Technology Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Shanghai Serum Bio Technology Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Serum Bio Technology Co (SHSE:688163) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Serum Bio Technology Co Ltd (SHSE:688163) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 1288, Huaqing Road, Qingpu District, Shanghai, CHN, 201707

Website

http://www.serum-china.com.cn

Shanghai Serum Bio Technology Co Ltd is engaged in the research, development, production and sales of preventive and therapeutic drugs in the field of biotoxins and biosafety.

Shanghai Serum Bio Technology Co (SHSE:688163) Headlines

No Headlines